Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancerGiampietro Gasparini, Dino Amadori, Matelda Zancan et al.|Breast Cancer Research and Treatment|2006Cited by 140
Hairy Cell Leukemia: A Clinical Review Based on 725 Cases of the Italian Cooperative Group (ICGHCL)Antonio Frassoldati, Vittorio Silingardi, Teresa Lamparelli et al.|Leukemia & lymphoma/Leukemia and lymphoma|1994Cited by 109
Changes of biological features in breast cancer cells determined by primary chemotherapyAntonio Frassoldati, Vittorio Silingardi, Francesca Adami et al.|Breast Cancer Research and Treatment|1997Cited by 40
ProMECE-CytaBOM vs MACOP-B in Advanced Aggressive Non-Hodgkin's Lymphoma: Long Term Results of a Multicenter Study of the Italian Lymphoma Study Group (GISL)Vittorio Silingardi, Caterina Mauri, Massimo Federico et al.|Leukemia & lymphoma/Leukemia and lymphoma|1995Cited by 22
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).Giuseppe Longo, Vittorio Silingardi, Claudia Fiorani et al.|PubMed|1999Cited by 11